PATENT CLAIM ANALYSIS

Application Number: 15752126
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "469000"]

Abstract:
Described herein are phenylsulfonamido-benzofuran derivatives, and pharmaceutically acceptable salts thereof. Also provided are pharmaceutical compositions, methods, uses, and kits involving compounds of Formulae (I), (II), (III), (IV), (V), or (VI) for treating and/or preventing proliferative diseases (e.g. cancers, inflammatory diseases, and autoimmune diseases) in a subject. The compounds and pharmaceutical compositions as described herein inhibit at least one protein of the BCL-2 family in a biological sample or subject to treat and/or prevent a proliferative disease. In certain embodiments, compounds described herein are selective inhibitors of MCL-1, a BCL-2 family member protein.

Claim (Index 28):
The method of  claim 1  comprising administering a compound of Formula (IV), or a pharmaceutically acceptable salt thereof, wherein R 7  is hydrogen.

Metadata:
- Claim Count in Document: 31.0
- Percentile: 88.0
- Lexical Diversity: 1.7971
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16095188', '15327705', '15737683', '14358606', '15737535']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7856312995717312
- 35 USC 102 Novelty (BERT): 0.5582383217344599
- Combined Prediction Score: 0.7628920017880041
- Mean Citation Score: 427.281194
- Max Citation Score: 432.5645
- Similarity Product: 328.98588294860724

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test